论文部分内容阅读
患者对药物不能控制的原发性开角型青光眼用氩激光小梁成形术控制高眼压在二个不同年龄组进行比较,40岁以下患原发性开角型青光眼的15只眼,其中有9只眼(60%)术后不能控制眼压,并且在行氩激光小梁成形术的两年内需要行滤过性手术,而较年老组经随访12—22个月,29只眼中仅有二只眼(7%)不能控制高眼压,且激光治疗后,较老年患者的眼压下降(12±6mmHg)比年青患者眼压下降(5±6 mmHg)为明显,而较年轻患者之所以失败与术前高眼压有关,因此氩激光小梁成形术对患原发性开角型青光眼的较年青病人不是一个可靠的有效疗法。虽然氩激光小梁成形术能有效的降低原发性开角型青光眼病人的眼压,但此手术不
Patients with non-controllable primary open-angle glaucoma with argon laser trabeculation control of intraocular hypertension in two different age groups compared to 40 years of age with primary open-angle glaucoma in 15 eyes, of which Nine eyes (60%) had no control of intraocular pressure after surgery and had undergone filtering surgery within two years of argon laser trabeculation, compared with 12-22 months in the older group and 29 eyes Only two eyes (7%) failed to control ocular hypertension, and after laser treatment, the reduction in intraocular pressure (12 ± 6 mmHg) was more pronounced in older patients than in younger patients (5 ± 6 mmHg) The failure of patients is associated with preoperative intraocular hypertension, so argon laser trabeculoplasty is not a reliable and effective therapy for younger patients with primary open-angle glaucoma. Although argon laser trabeculoplasty can effectively reduce the intraocular pressure in patients with primary open-angle glaucoma, but this surgery is not